239 related articles for article (PubMed ID: 29894518)
1. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
[TBL] [Abstract][Full Text] [Related]
2. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.
WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group
BMC Med; 2015 Sep; 13():227. PubMed ID: 26381375
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F
Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
[TBL] [Abstract][Full Text] [Related]
7. Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.
Kloprogge F; McGready R; Hanpithakpong W; Blessborn D; Day NP; White NJ; Nosten F; Tarning J
Antimicrob Agents Chemother; 2015 Oct; 59(10):6375-84. PubMed ID: 26239986
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Tarning J; McGready R; Lindegardh N; Ashley EA; Pimanpanarak M; Kamanikom B; Annerberg A; Day NP; Stepniewska K; Singhasivanon P; White NJ; Nosten F
Antimicrob Agents Chemother; 2009 Sep; 53(9):3837-46. PubMed ID: 19564366
[TBL] [Abstract][Full Text] [Related]
9. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S;
Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Onyamboko MA; Hoglund RM; Lee SJ; Kabedi C; Kayembe D; Badjanga BB; Turner GDH; Jackson NV; Tarning J; McGready R; Nosten F; White NJ; Day NPJ; Fanello C
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818818
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
[TBL] [Abstract][Full Text] [Related]
13. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
[TBL] [Abstract][Full Text] [Related]
14. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
[TBL] [Abstract][Full Text] [Related]
15. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations.
Thomford NE; Kellermann T; Biney RP; Dixon C; Nyarko SB; Ateko RO; Ekor M; Kyei GB
Malar J; 2024 Apr; 23(1):125. PubMed ID: 38685044
[TBL] [Abstract][Full Text] [Related]
17. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group
Lancet Infect Dis; 2015 Jun; 15(6):692-702. PubMed ID: 25788162
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Whalen ME; Kajubi R; Goodwin J; Orukan F; Colt M; Huang L; Richards K; Wang K; Li F; Mwebaza N; Aweeka FT; Parikh S
Clin Infect Dis; 2023 Feb; 76(3):443-452. PubMed ID: 36130191
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
[TBL] [Abstract][Full Text] [Related]
20. Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Hughes E; Mwebaza N; Huang L; Kajubi R; Nguyen V; Nyunt MM; Orukan F; Mwima MW; Parikh S; Aweeka F
J Acquir Immune Defic Syndr; 2020 Feb; 83(2):140-147. PubMed ID: 31929402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
